2 April 2025
Talking Nutrition, Health & Care
Our latest articles, covering industry news, new science, consumer insights and more.
Featured story
Discover our new portfolio of taste solutions for pharmaceutical formulations
The demand for patient-friendly medications is growing. Pill fatigue, dysphagia, and taste aversion may impact patient compliance to medication, prompting drug developers to rethink existing or create new formulations that are both effective and palatable.
In response, dsm-firmenich has launched a new portfolio of taste solutions designed specifically for pharmaceutical applications, helping manufacturers to overcome common taste and sensory challenges.
Latest articles
-
-
31 March 2025
Turn the tide against global malnutrition: The importance of cross-sector collaboration
-
24 March 2025
Introducing dsm-firmenich’s new portfolio of taste solutions for pharmaceutical formulations
-
11 March 2025
What's next for gut health? 5 breakthrough trends from Probiota 2025
-
21 February 2025
New CBD bioavailability study with CBtru®
-
12 February 2025
Unlock mineral bioavailability: How phytase breaks through absorption barriers
-
31 January 2025
Ask-the-Expert: Explore a new human milk oligosaccharide (HMO) review revealing how HMO combinations can support infant health
-
16 January 2025
Scientific innovation based on natural inspiration: Emerging trends in early life nutrition
-
10 January 2025
Insights from a surgeon: How can omega-3s elevate perioperative nutrition?
-
18 December 2024
What does the latest gut health research tell us about Humiome® B2’s potential for a healthy gut microbiome? Ask the scientist
Latest Press Releases
-
14 April 2025
From cellular aging to gut microbiome: dsm-firmenich highlights solutions to advance nutrition at Vitafoods 2025
dsm-firmenich, a leading innovator in health, nutrition and beauty, is set to showcase solutions that advance nutrition at Vitafoods Europe 2025 on booth 3G58 with a display of its latest innovations in healthy longevity, gut health and more.
-
11 April 2025
Boost for infant health: India approves dsm-firmenich's 2'-FL HMO
dsm-firmenich, a global innovator in health, nutrition and beauty, has today announced the approval of its human milk oligosaccharide (HMO), 2'-O-Fucosyllactose (2'-FL)—commercially known as GLYCARE® 2FL—as a functional ingredient for early life nutrition in India. This regulatory milestone marks a new opportunity to enhance infant health, as well as support HMO innovation in the region, with GLYCARE® 2FL representing dsm-firmenich’s first HMO approval in India.
-
2 April 2025
Initial evidence suggests a role for synbiotic supplements in managing digestive discomfort and enhancing behavioral wellbeing in autistic children
Evidence from a clinical study deepens insight into role of the gut-brain axis, marking progress towards a more holistic strategy for managing gastrointestinal (GI), irritability and anxiety-related symptoms in autistic children with synbiotics, either alone or in combination with gut-directed hypnotherapy (GDH).
How can we help you?
-
New partnership request
Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.
-
Sample request
Don’t just take our word for it. Discover how our solutions can support your product development journey.
-
Quick links
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
From trade shows to conferences and other industry events, find out where you can meet us next.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.